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Sp1 activates the transcription of many cellular and
viral genes with the GC-box in either the proximal pro-
moter or the enhancer. Sp1 is composed of several func-
tional domains, such as the inhibitory domain (ID), two
serine/threonine-rich domains, two glutamine-rich do-
mains, three C2H2-type zinc finger DNA binding do-
mains (ZFDBD), and a C-terminal D domain. The ZDDBD
is the most highly conserved domain among the Sp-fam-
ily transcription factors and plays a critical role in GC-
box recognition. In this study, we investigated the pro-
tein-protein interactions occurring at the Sp1ZFDBD
and the Sp1ID, and the molecular mechanisms control-
ling the interaction. Our results found that Sp1ZFDBD
and Sp1ID repressed transcription once they were
targeted to the proximal promoter of the pGal4 UAS
reporter fusion gene system, suggesting molecular in-
teraction with the repressormolecules. Indeed, mamma-
lian two-hybrid assays, GST fusion protein pull-down
assays, and co-immunoprecipitation assays showed that
Sp1ZFDBD and Sp1ID are able to interact with core-
pressor proteins such as SMRT, NcoR, and BCoR. The
molecular interactions appear to be regulated by MAP
kinase/Erk kinase kinase (MEK). The molecular interac-
tions between Sp1ID and the corepressor might explain
the role of Sp1 as a repressor under certain circum-
stances. The siRNA-induced degradation of the core-
pressors resulted in an up-regulation of Sp1-dependent
transcription. The cellular context of the corepressors
and the regulation of molecular interaction between
corepressors and Sp1ZFDBD or Sp1ID might be impor-
tant in controlling Sp1 activity.
Transcriptional regulation of the eukaryotic gene is a com-
plicated process, involving a series of complex molecular inter-
actions among regulatory and transcription factors. Specificity
protein 1 (Sp1)1 is probably one of the best characterized se-
quence-specific transcription factors, and has numerous func-
tions in the transcription of many cellular and viral genes
harboring GC boxes in their promoters (1, 2). Sp1 and its family
of proteins have been implicated in a host of essential biological
processes, and have been proven important in apoptosis, cell
growth inhibition, differentiation, and carcinogenesis (Refs.
3–5 and references therein).
Sp1 is a member of the Sp-multigene family, which also
includes Sp2, Sp3, Sp4, Sp5, Sp6, Sp7, and Sp8 (3–5). The
Sp-family proteins exhibit similar domain structures and are
evolutionarily closely related. All of these proteins possess
highly conserved C2H2-type zinc finger DNA binding domains
at their C termini, and all belong to the Kru¨ppel-like zinc finger
superfamily (3–5). In addition, the Sp-family proteins have
been demonstrated to undergo post-translational modifications
as the result of diverse mechanisms. For example, Sp1 is gly-
cosylated and phosphorylated by Erk2, protein kinase C, ca-
sein kinase II, and cAMP-dependent protein kinase; Sp3 is
acetylated and SUMOylated by the protein inhibitor of acti-
vated STAT (PIAS1, Ref. 3 and references therein, Refs. 6–10).
The Sp1 protein comprises several domains. These domains
include the N-terminal inhibitory domain (amino acids 1–82,
ID), serine/threonine-rich domains (amino acids 87–143; amino
acids 243–350, Ser/Thr-rich region), glutamine-rich domains
(amino acids 138–232; amino acids 351–500, Gln-rich region),
the zinc finger DNA binding domain (amino acids 622–720,
ZFDBD), and the C-terminal D domain (amino acids 721–788)
(3–5). The Ser/Thr-rich region is regulated by phosphorylation
and is crucial in the regulation of Sp1. The Gln-rich region,
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which has the essential characteristics of an acid-blob, has
been implicated in transcriptional activation. The ZFDBD of
Sp1 is the most highly conserved region among the Sp-family
proteins. The D domain also plays an important role in the
synergistic activation of Sp1 (11).
Sp1 binds to the GC boxes located in the proximal promoters
or enhancers found in almost all genes (3–5). In general, it acts
as a transcriptional activator (and as a repressor in some
cases), and the cellular context of the Sp-family is important
with regard to the regulation of transcription (12–14). For
example, Sp1 activates many different types of genes, including
simian virus 40 (SV40), thymidine kinase (TK), and many
mammalian housekeeping and tissue-specific genes (3–5). To
activate transcription, Sp1 also interacts with nuclear proteins
such as the TATA-box-binding protein TBP, and the TBP-
associated factors dTAFII130, hTAFII130, hTAFII55, and
CRSP (a cofactor required for Sp1 activation). Sp1 also inter-
acts with a variety of other transcription factors, such as the
retinoblastoma-related proteins p107, YY1, E2F, HDAC1,
p300, and FBI-1 (9, 15–22). Currently, available data suggest
that Sp1 acts mainly as a transcription activator, but also, in
some cases, as a transcription repressor (Refs. 1, 3–5 and
references therein, Refs. 20–24). Indeed, many reports have
implied that Sp1 and the Sp1-like transcription factors exhibit
a bipolar character; i.e. they function as either transcription
activators or repressors, depending on the promoter to which
they bind and the coregulators with which they interact (1, 2, 9,
12–14, 23–27).
The Sp-family exhibits several highly conserved domains, as
stated above. Accordingly, it would appear that a certain mech-
anism exists for the regulation of Sp-family activities, function-
ing via these highly conserved domains, regardless of their
properties as either transcription activators or repressors. Par-
ticular attention has been currently focused on the most highly
conserved domain, the ZFDBD. It has been hypothesized that
there is a reason, other than target recognition, for the high
degree of conservation seen in the amino acid sequences of the
ZFDBDs in the Sp-family transcription factors. It may interact
with other regulatory proteins, and the protein involved in the
interaction might function as a negative or positive regulator
by controlling the GC-box target recognition of the Sp-family
ZFDBDs.
The molecular mechanism underlying the repressor func-
tions of Sp1 in the expression of some genes remains uncertain.
The molecular role of the N-terminal ID (inhibitory domain)
present in full-length Sp1 cDNA has not yet been character-
ized, due both to the lack of full-length Sp1 cDNA (GenBankTM
accession number NM_138473 XM_028606) and to the widely
circulating truncated version of Sp1 originally cloned by the
Tjian group (2). Full-length cDNA, containing the N-terminal
ID, has been cloned only very recently (28; GenBankTM acces-
sion number NM_138473 XM_028606), and its ID may well
play a role in the Sp1-mediated repression of transcription.
In this study, we discovered that the ZFDBD and ID domains
of Sp1 are involved in protein-protein interactions with the
other transcription regulatory molecules: the corepressors
SMRT, NCoR, and BCoR (29–31). We also determined that
these interactions are important in the transcriptional regula-
tion of Sp1. Our results indicate that these interactions could
be regulated by MEK, a component of the MAP kinase/Erk
kinase signaling pathway.
EXPERIMENTAL PROCEDURES
Plasmid Construction—The mammalian expression plasmids for the
Gal4-zinc finger domain (amino acids 622–720) fusion proteins or the
inhibitory domain (amino acids 1–82) fusion proteins of Sp1 were con-
structed by subcloning the ZFDBD or ID cDNA into a pCMX-Gal4
fusion expression plasmid. The expression plasmids for the VP16-core-
pressors, the NCoR (amino acids 1709–2215), SMRT (amino acids 194–
657), and BCoR (amino acids 112–753) fusion proteins (pKH73/110EF-
NCoR, pKH135EF-BCoR), were kindly provided by Drs. Ronald Evans
(The Salk Institute), Vivian Bardwell (University of Minnesota), and
Dominique Leprince (Institut Pasteur de Lille) (29–31). To generate the
GST fusion protein expression plasmids, the ZFDBD and the ID do-
mains of Sp1 were subcloned into pGEX4T3 (Amersham Biosciences).
The mammalian expression plasmids were prepared by subcloning the
cDNA fragments encoding for SMRT (amino acids 194–657), NCoR
(amino acids 1709–2215), and BCoR (amino acids 112–753) into
pcDNA3.0 (Invitrogen) (29–31).
Interactions between the Sp-family and its corepressors and reporter
assays were assessed via the cloning of five tandem Sp1 binding sites
(sense: 5-CTAGCTCGATCGGGGCGGGGCGAGCG-3; antisense: 5-
CTAGCGCTCGCCCCGCCCCGGATCGAG-3) upstream of the adeno-
virus major late promoter in the vector, pG5-Luc (Promega), to generate
pG5–5x(GC)-Luc. All constructs were verified by sequencing. The plas-
mids of the MAP kinase/Erk kinase signaling pathway were kindly
provided by Dr. K.-Y. Choi of Yonsei University (Seoul, Korea).
Cell Culture and Mammalian Two-hybrid Reporter Assays—African
green monkey kidney cells (CV-1) were grown in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum,
100 units/ml of streptomycin, and 100 units/ml of penicillin (Invitro-
gen). The cells were inoculated on 6-well tissue culture plates, at a
density of 1 105 cells/well in 2 ml of DMEM. After the cells had grown
for 24 h, they were transiently transfected with the Gal4 fusion bait
expression plasmid, the VP16 fusion effector plasmid, and the reporter
plasmid, using Lipofectamine Plus reagent (Invitrogen) in serum-free
DMEM, according to the manufacturer’s recommendations. After 3 h,
the cells were supplied with fresh, complete DMEM, and allowed to
grow for 48 additional hours. The cells were then harvested and lysed in
150 l of reporter lysis buffer (Promega), vortexed for 1 min, and then
centrifuged at 12,000 rpm for 3 min at 4 °C. The luciferase reporter
assays were performed with 5 l of cell extracts, using 50 l of lucifer-
ase assay reagent (Promega) on a luminometer (Microplate Luminom-
eter LB 96V, EG&G Berthold). Luciferase activities were normalized to
either the protein concentration or to -galactosidase activity. The
protein concentration of the cell extracts was determined by the Brad-
ford method (32).
Recombinant Sp1 Zinc Finger DNA Binding Domain Expression—A
recombinant Sp1 zinc finger DNA binding domain expression vector
was constructed by cloning the cDNA fragment encoding from amino
acids 624 to 718 of Sp1 into pTrcHisB/Bam H1 (Invitrogen) to generate
pTrcHisB-Sp1ZF. pTrcHisB-Sp1ZF was introduced into Escherichia
coli BL21(DE3) by transformation and cultured at 18 °C in the presence
of 0.2 mM isopropyl-1-thio--D-galactopyranoside. E. coli were har-
vested and then lysed by sonication. Recombinant Sp1ZFWt polypep-
tide was purified by Ni-nitrilotriacetic (NTA) acid bead column
affinity chromatography.
Site-directed Mutagenesis of pTrcHisB-Sp1ZF and pGal4-Sp1ZF-
—To investigate the role of each zinc finger of Sp1, mutations were
introduced into the Sp1 zinc finger sequence of pTrcHisB-Sp1ZF or
pGal4-Sp1ZF using the QuikChange site-directed mutagenesis kit (St-
ratagene, La Jolla, CA). To introduce a mutation at the zinc fingers, the
following oligonucleotides were used (only top strands are shown): zinc
finger 1, amino acids 628 cysteine to serine, 5-TTCGGTACCAAACA-
GCATATTAGCCACATCCAAGGCTG-3; zinc finger 2, amino acids 658
cysteine to serine, 5-GCGAGAGGCCATTTATGAGTACCTGGTCATA-
CTG-3; zinc finger 3, amino acids 688 cysteine to serine, GGTGAGA-
AGAAATTTGCCAGCCCTGAGTGTCCTAAG. Recombinant Sp1ZF
mutant polypeptides were purified by Ni-NTA bead column affinity
chromatography after overexpression in E. coli BL21(DE3).
Electrophoretic Mobility Shift Assays (EMSAs)—EMSAs were car-
ried out as described previously (14). The sequences of Sp1 binding
GC-box oligonucleotides are as follows: top strand, 5-GATCATTC-
GATCGGGGCGGGGCGAGC-3; bottom strand, 5-GATCGCTCGC-
CCCGCCCCGATCGAAT-3. Each binding reaction was carried out in
20 l and contained 10 mM HEPES (pH 7.9), 60 mM KCl, 1 mM dithio-
threitol, 1 mM EDTA, 7% glycerol, and recombinant Sp1 zinc finger
wild-type or mutant proteins (0.1 g). Where indicated, an antibody
against Express epitope peptide (Invitrogen) was added to the EMSA
binding mixture.
GST Fusion Protein Purification, in Vitro Transcription and Trans-
lation of Corepressors—GST and GST fusion protein expression were
induced in E. coli ER2566 via the addition of 0.5 mM isopropyl-1-thio-
-D-galactopyranoside and with 5 h of incubation. The cells were lysed
and purified with glutathione-agarose 4 bead affinity chromatography
(Peptron, Daejeon, Korea). The purified proteins were then resolved
Regulation of Sp1 Transcription Activity by Corepressors28062
 at Y
O
N
SEI U
N
IV
ERSITY
 on July 1, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
with 10% SDS-PAGE, and the protein concentrations were determined
by the Bradford method (26).
The in vitro translated corepressor polypeptides were prepared by
incubating the pcDNA3.0 corepressor expression plasmids (1 g) with
TNT Quick-coupled Transcription/Translation Extract (Promega), con-
taining 40 l of TNT Quick Master Mix, 4 l of [35S]methionine (1175.0
Ci/mol, PerkinElmer Life Sciences, Inc.), and 4 l of amino acid mixture
minus the methionine, at 30 °C for 90 min. Polypeptide expression
levels were then analyzed by running 2 l of the total mixture with
10% SDS-PAGE.
GST Fusion Protein Pull-down Assays—The purified GST fusion
proteins (5 g) were incubated with GSH-agarose (Sigma) for 1 h in
HEMG buffer (40 mMHEPES, pH 7.9; 100 mM KCl, 0.2 mM EDTA, 5 mM
MgCl2, 0.1% Nonidet P-40, 10% glycerol, 1.5 mM dithiothreitol; and
protease inhibitor mixture, 1 tablet/50 ml of a protease inhibitor mix-
ture, Roche Applied Science) at 4 °C. After the agarose-GST protein
complexes had been washed three times with 1 ml of cold HEMG buffer,
20 l of the [35S]methionine-labeled corepressors were incubated for 4 h
in HEMG buffer at 4 °C. The reaction mixtures were centrifuged at
3,000  g at 4 °C, and the supernatants were removed and washed five
times with cold HEMG buffer. The bound proteins were separated by
10% SDS-PAGE, and the SDS-PAGE gels were dried and exposed to
x-ray film using image-intensifying screens (Kodak).
Co-immunoprecipitation of FLAG-tagged Full-length Sp1 Protein
with Corepressors—HA and FLAG epitope-tagged full-length Sp1 ex-
pressed from Drosophila SL2 cells was purchased from Alexis Bio-
chemicals (San Diego, CA). The [35S]methionine-labeled corepressors
were prepared using the TNT Quick-coupled Transcription/Translation
System. Sp1 (10 ng) and [35S]methionine-labeled corepressor proteins
(10 l each) were mixed together and incubated overnight at 4 °C with
a rotating rocker. The protein mixtures were incubated further with
M2-anti-FLAG antibody-agarose beads (Sigma) for 2 h. Protein-anti-
body-agarose complexes were precipitated, washed, and analyzed by
SDS-PAGE and autoradiography. In vitro translated [35S]methionine-
labeled luciferase was used as a control.
Chromatin Immunoprecipitation (ChIP) Assays—We investigated
whether in vivo molecular interaction between Sp1ID and corepressors
on the UAS element on the pG5-Luc promoter could affect the histone
acetylation status using the ChIP assay kit (Upstate Biotechnology,
Inc.) (33, 34). Subconfluent CV-1 cells on a 10-mm dish were transfected
with pG5-UAS-Luc (2 g) and pGal4, pGal4Sp1ZF, or pGal4-Sp1ID (3
g) using Lipofectamine Plus and grown another 48 h. CV-1 cells were
treated with formaldehyde (final 1%) to cross-link Gal4 or Gal4 fusion
protein to the UAS of pG5-UAS-Luc DNA. Cells were washed with cold
phosphate-buffered saline and lysed with SDS lysis buffer (1% SDS, 10
mM EDTA, 50 mM Tris-HCl, pH 8.1). The lysate was sonicated to shear
DNA to a length between 200 and 1000 bp. The sonicated supernatant
was diluted 10-fold with ChIP dilution buffer (0.01% SDS, 1% Triton
X-100, 2 mM Tris-HCl, pH 8.1, 150 mM NaCl) and incubated with
antibodies against acetylated histone (Upstate Biotechnology) or pre-
immune serum overnight at 4 °C with rotation. To collect DNA-histone-
antibody complex, a salmon sperm DNA/protein A-agarose slurry was
added to the mixture. The mixture was incubated for 1 h at 4 °C with
rotation and pelleted in a DNA/protein A-agarose complex by brief
centrifugation (700–1000 rpm) at 4 °C. After extensive washing of the
pellet with various washing buffers recommended by the manufacturer,
the pellet was dissolved with 250 l of elution buffer and spun to
remove agarose. Supernatant was treated with 20 l of 5 M NaCl and
heated to 65 °C for 4 h to reverse Gal4 or Gal4 fusion polypeptide-DNA
cross-link. After treatment with EDTA and proteinase K, the superna-
tant was extracted with phenol/chloroform and precipitated with etha-
nol to recover DNA. PCR reactions of immunoprecipitated DNA were
carried out using the forward primer, 5-GGATCCGAGTTTCTAGACG-
GAG-3 and the reverse primer, 5-TTATGTTTTTGGCGTCTTCC-3.
Regulation of Molecular Interaction between the Sp1ZFDBD or
Sp1ID and Corepressors—We examined whether the molecular inter-
actions between the Sp1ZFDBD or Sp1ID and corepressors could be
modulated by members of the MAP kinase/Erk kinase signaling path-
ways using the mammalian two-hybrid assays. The CV-1 cells were
cotransfected with pG5-Luc (0.3 g), the expression plasmids for pGal4-
Sp1ZFDBD (0.25 g), the VP16-corepressor (0.25 g), -galactosidase
(0.1 g), and various components of the MAP kinase/Erk kinase signal-
ing pathway including MEK (0.3 g). After 48 h of transfection with
Lipofectamine Plus, the CV-1 cells were harvested and assayed for
luciferase activity. Luciferase activity was then normalized with -ga-
lactosidase activity.
We also tested whether MEK, a modulator of molecular interaction
between Sp1ZFDBD or Sp1ID and the corepressors, could affect the
transcription of the three Sp1-dependent promoter reporter fusion con-
structs. The pG5–5x(GC)-Luc reporter plasmid (0.2 g), the p21Waf/Cip1-
Luc (0.2 g), and the ADH5/FDH-Luc reporter plasmid (0.2 g) were
cotransfected into CV-1 cells, either with or without the expression
plasmids of the constitutive activator (MEKCA), the dominant negative
form (MEKDN) of MEK (0.8 g), and pCMV--galactosidase (0.2 g).
The transfection and reporter assays were performed as described
above.
In addition, we also tested whether the Erk activator, EGF (50
ng/ml), or the U0126 MEK inhibitor (10 nM, Cell Signaling Technology)
could affect the transcription of pG5–5x(GC)-Luc, p21Waf/Cip1-Luc, and
ADH5/FDH-Luc. The CV-1 cells were transfected with pG5–5x(GC)-Luc
or pGL2-ADH5/FDH-Luc (0.8 g) and pCMV--gal (0.2 g), according
to the procedures described above, and the cells were treated with EGF
or U0126 for 24 h before harvesting.
Knockdown of Corepressor mRNA and Expression by siRNA—The
siRNA pools of the SMRT, NCoR, and BCoR corepressors were pur-
chased from Dharmacon (catalog numbers M-020145, M-004584,
M-003518; West Lafayette, IN). The siRNA for glyceraldehyde-3-phos-
phate dehydrogenase was purchased from Ambion Inc. (TX) (catalog
number 4605). A mixture of the siRNA pool (20 ng of each) and the
plasmids (0.3 g pG5–5x(GC)-Luc promoter and 0.1 g pCMV--gal)
was transfected into HeLa cells (6  106 cells) by electroporation, as
described by AMAXA Inc. (Gaithersburg, MD). After cell transfection,
the cells were harvested, and extracts were prepared. Reverse tran-
scriptase-PCR was performed with one-third of the cellular extracts to
confirm corepressor mRNA knockdown, and the other two-thirds were
used to analyze the luciferase and -galactosidase activities.
RESULTS
Sp1ZFDBD and Sp1ID Can Repress Transcription Once Tar-
geted to the Proximal Promoter of the Yeast GAL4-UAS Re-
porter System—Previous reports revealed that Sp1ZFDBD in-
teracts with the HDAC1 and POZ domains (21, 22). It was
suspected that the Sp1ZFDBD and the Sp1ID might also in-
teract with the other polypeptides involved in transcription
repression, and that these interactions may be important in the
regulation of Sp1 activity. To investigate this possibility, Gal4-
Sp1ZFDBD fusion protein expression plasmids were prepared
by subcloning cDNA fragments coding for Sp1ZFDBD (amino
acids 622–720) and Sp1ID (amino acids 1–82) into a pCMX-
Gal4 fusion expression vector. The CV-1 cells were transfected
with pGal4-UAS luciferase plasmids (pG5-Luc) and Gal4-
Sp1ZFDBD or -Sp1ID fusion expression plasmids, and after
48 h, luciferase activity was analyzed. The Gal4-Sp1ZFDBD or
Gal4-Sp1ID was targeted to the proximal UAS and exhibited
strong inhibitory effects on the transcription of the reporter
gene compared with the Gal4DBD control (Fig. 1). Both
Sp1ZFDBD and Sp1ID repressed transcription by more than
95%, which indicates that Sp1ZFDBD or Sp1ID might be in-
teracting with the regulatory proteins involved in transcription
repression.
The Mammalian Two-hybrid Assays Showed That the
ZFDBD and ID of Sp1 Interact with Corepressors in Vivo—Our
data suggest that both Sp1ZFDBD and ID might interact with
the repressor or corepressor proteins that can inhibit transcrip-
tion in the test promoter. Accordingly, we investigated whether
the Sp1ZFDBD or Sp1ID could interact with the corepres-
sors such as SMRT, NCoR, and BCoR, all of which have been
shown to repress transcription (29–31), using mammalian
two-hybrid assays.
Transient transfection assays in CV-1 cells indicated that
the Sp1ZFDBD or Sp1ID both interacted strongly with SMRT,
NCoR, and BCoR (Fig. 2B). The interaction between the
Sp1ZFDBD and the VP16 corepressors resulted in an increase
in transcription by 2–7.7-fold, depending on the corepressors,
and the Sp1ZFDBD was found to interact most vigorously with
BCoR. Also, the N-terminal Sp1ID interacted robustly with the
corepressors, increasing transcription by 3.5–8.5-fold over the
control (Fig. 2C). SMRT and BCoR both exhibited robust inter-
actions with the Sp1ID.
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These results indicate that either the Sp1ZFDBD or the
Sp1ID interacts with the corepressors in vivo. This suggests
that Sp1ZFDBD is probably not in its naked state and may be
forming a complex with the corepressors. In addition, these
molecular interactions with the corepressors may constitute a
key factor in the transcriptional regulation of the Sp-family, via
the modulation of the target GC-box binding of Sp1ZFDBD.
Moreover, the molecular interactions occurring between Sp1ID
and the corepressors may explain the transcription repression
by the Sp1 bound to the enhancer or to the proximal promoter
GC-box (23–27).
The Mutation of Sp1ZFDBD Does Not Affect Interaction with
Corepressors in Vivo—The above data indicate that the
Sp1ZFDBD probably interacts with the corepressor proteins
that inhibit transcription on the test pUAS-Luc promoter.
However, one can argue that the Sp1ZFDBD targeted to the
proximal promoter of pUAS-Luc via Gal4DBD can repress
transcription by binding to the promoter GC-box of other genes.
Such interactions with other promoters can deplete the general
transcription available to pUAS-Luc and can also repress tran-
scription in trans by the repressors bound to the other GC-box-
containing promoters.
Therefore, we prepared three recombinant mutant Sp1 zinc
fingers by changing each one of the three cysteine residues
critical in their formation into serine, by site-directed mutagen-
esis (Fig. 3A). EMSA showed that mutation at the first zinc
finger resulted in a markedly decreased binding activity of the
Sp1 zinc finger to the GC-box probes. In contrast, mutations
introduced at the second and third zinc fingers of Sp1 abolished
the binding of recombinant mutant zinc finger proteins to the
GC box (Fig. 3B). Having generated the mutant Sp1ZF
polypeptides lacking the ability to bind to the GC-box, we used
mammalian two-hybrid assays to test whether the Sp1ZF mu-
tant could still interact with the corepressors in vivo. The
mutant Sp1ZFM2 targeted by Gal4DBD to UAS also interacted
strongly with SMRT and BcoR, and moderately with NcoR, just
like the Sp1ZF (Fig. 3C). Accordingly, our data suggest that
transcription repression by Gal4Sp1ZF occurs via interaction
with corepressor proteins, and not by the binding of Sp1ZF to
the GC-box of other promoters with repressor or corepressors
bound nearby, or by the competitive depletion of general tran-
scription factors by other promoters.
The Sp1ZFDBD and Sp1ID of Sp1 Directly Interact with the
Corepressors in Vitro—To investigate whether the molecular
interaction between the Sp1ZFDBD or Sp1ID and the corepres-
sors is direct, a GST fusion protein pull-down assay was per-
formed using recombinant GST-Sp1ZFDBD, GST-Sp1ID, and
in vitro translated corepressor proteins. The GST and GST-
Sp1ZFDBD or -Sp1ID were immobilized onto agarose and in-
cubated with [35S]methionine-labeled corepressor polypeptides
prepared with the TNT Quick-coupled Transcription/Transla-
tion system. After the precipitation and extensive washing of
FIG. 1. Transcription repression by proximal-promoter-tar-
geted Sp1ZFDBD and Sp1ID. A, structures of the UAS-luciferase
reporter plasmid and the Gal4DBD-Sp1ZFDBD or -Sp1ID fusion pro-
teins bound to UAS, the upstream activator sequence. B, proximal
promoter-targeted Sp1ZFDBD represses transcription. Sp1ID also vig-
orously represses transcription. The CV-1 cells were transiently trans-
fected with the UAS luciferase reporter plasmid, pG5-Luc, and the
expression plasmids of Gal4-Sp1ZFDBDs and Gal4-Sp1ID fusion pro-
teins. The cell extracts were analyzed for their reporter luciferase
activities, and were normalized with -galactosidase activity. Arrow
(3) and Tsp, transcription start point. Data are taken as an average of
three independent assays. Bar represents S.D.
FIG. 2. The Sp1ZFDBD and Sp1ID interact with the corepres-
sors in vivo. A, structure of the UAS-luciferase reporter plasmid used
in the mammalian two-hybrid assays. B, Sp1ZFDBD interacts with the
corepressors SMRT, NCoR, and BCoR. C, Sp1ID also interacts with
corepressors. The interactions differ considerably, according to the core-
pressors tested. The CV-1 cells were transfected with pG5-Luc, the
GAL4 bait fusion protein expression plasmids, the VP16 fusion protein
expression plasmids, and the control pCMV -galactosidase expression
plasmids. The cells were harvested and analyzed for their reporter
luciferase activities. Cell extracts were analyzed for their reporter ac-
tivities, normalized with -galactosidase activity. Data are an average
of three independent assays. Bar represents S.D.
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the complex, the precipitants were analyzed via SDS-PAGE
and autoradiography. Our results indicated that both
Sp1ZFDBD and Sp1ID interact directly with the corepressor
polypeptides (Fig. 4), which suggests that the molecular inter-
actions evidenced by the mammalian two-hybrid assays do
indeed exist. In addition, we determined that the interaction
involved the following modules of corepressor molecules: amino
acids 194–657 of SMRT, amino acids 1709–2215 of NCoR, and
amino acids 112–753 of BCoR (29–31). These domains were
previously shown to interact with POZ domains, and are im-
portant in transcription repression (29, 35).
We also tested whether the full-length Sp1 protein can in-
teract with the corepressors, because the Sp1ZFDBD and
Sp1ID can potentially be buried inside of Sp1. The full-length
FLAG epitope-tagged Sp1 and [35S]methionine-labeled core-
pressor polypeptides were incubated together and co-immuno-
precipitated using anti-FLAG antibody conjugated to agarose
beads (M2-FLAG-agarose). SDS-PAGE and autoradiography of
the precipitates showed that the full-length Sp1 was also able
to interact with the corepressors, but the control luciferase did
not interact with the corepressors (Fig. 4C).
ChiP Assays Show That Sp1ID Binds to the UAS Promoter
Region of pG5-UAS-Luc and Deacetylates Histone in Vivo—The
interaction between the cis-regulatory UAS proximal promoter
element of the pG5-Luc and Gal4-Sp1ID in vivo and resulting
histone modification was investigated by ChIP assay. After
cross-linking of the chromatin with protein using formalde-
hyde, sheared chromatin was immunoprecipitated with puri-
fied polyclonal anti-acetylated histone antibody and Sepharose
A. PCR amplifications of unsheared input genomic DNA and
anti-acetylated histone 4 antibody-mediated immunoprecipi-
tant of the cells transfected with Gal4 expression plasmid gave
PCR products of the expected size (246 bp), but the same
reaction with precipitant prepared from the cells transfected
only with Gal4-Sp1ID expression plasmid did not give ampli-
fied product (Fig. 5B). The data suggested that Gal4-Sp1ID
interacts with the UAS of pG5-Luc in vivo and interacted with
corepressors, which deacetylated histone and repressed tran-
scription (Fig. 5C).
The Molecular Interactions between the Sp1ZFDBD and the
Corepressors Are Controlled by MEK of the MAP Kinase/Erk
Kinase Signaling Pathway in Vivo—The molecular interactions
FIG. 3. Themutation of the Sp1 zinc finger significantly affects
or abolishes GC-box recognition, and the Sp1ZFmutant can still
interact with the corepressors in vivo. A, top, structure of Sp1ZF
and Sp1ZF mutants (M1–3). Sp1 contains three zinc fingers, and mu-
tations were introduced in each one of the three zinc fingers. Bottom, an
SDS-PAGE gel of recombinant zinc finger proteins expressed in E. coli
and used for EMSA. B, EMSA of 32P-labeled GC-box probes with re-
combinant wild-type Sp1ZF and mutant Sp1ZFM1, -M2, and -M3 pro-
teins. C, mammalian two-hybrid assays. Sp1ZF mutant, Sp1ZFM2,
interacts with corepressors. The interaction differs considerably, ac-
cording to the corepressors tested. The CV-1 cells were transfected with
pG5-Luc, the Gal4 bait fusion protein expression plasmids, the VP16
fusion protein expression plasmids, and the control pCMV -galacto-
sidase expression plasmids. The cells were harvested and analyzed for
their reporter luciferase activities. Cell extracts were analyzed for their
reporter activities, normalized with -galactosidase activity. Data are
an average of three independent assays. Bar represents S.D.
FIG. 4. The Sp1ZFDBD and Sp1ID proteins interact directly
with the corepressors in vitro. A, structure of the corepressors,
SMRT, NCoR, and BCoR, and of Sp1. RD, repression domain; N3–1 and
S1–2, domains involved in interaction with nuclear receptors. Domains
of corepressors used in in vitro pull-down assays are indicated below by
light gray filled bars. ZF, zinc finger domain; A and B, two glutamine
and serine/threonine-rich domains; D, D-domain; *, two Sp1 domains
(ID and ZF) used in pull-down of [35S]methionine-labeled corepressors
polypeptides. B, recombinant GST, GST-Sp1ZFDBD, and GST-Sp1ID
fusion proteins were incubated with the in vitro synthesized [35S]me-
thionine-labeled corepressor polypeptides, and then were pulled down.
The precipitated samples were resolved by 10% SDS-PAGE and ex-
posed to x-ray film. input, 10% of the corepressors added in the binding
reactions. C, co-immunoprecipitation showed that the full-length
FLAG-tagged Sp1 can also interact with corepressors (SMRT, BcoR,
NcoR), whereas the control luciferase cannot. Control, [35S]methionine-
labeled luciferase; WB, Western blot.
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between the Sp1ZFDBD or Sp1ID and the corepressor proteins
are apparent both in vivo and in vitro. The protein-protein
molecular interactions should be regulated in order to have
significance with regard to gene expression. We tested whether
the molecular interactions between the Sp1ZFDBD or Sp1ID
and the corepressors could be regulated by the components of
the MAP kinase/Erk kinase signaling pathway by adapting the
mammalian two-hybrid assay. The molecular interaction be-
tween SMRT and Sp1ZFDBD increased reporter activity 4-fold
(Fig. 6A). Interestingly, among the components tested, MEKCA
resulted in a decrease in reporter gene expression. In contrast,
MEKDN resulted in a significant increase in the reporter gene
expression over the control (Fig. 6A). Similar results were
obtained with the Sp1ZFDBD and corepressor NCoR (Fig. 6B).
These results suggest that the molecular interaction occurring
between the Sp1ZFDBD and the corepressor SMRT or NCoR
can be regulated by the MEK, and the MEK weakens the
interaction. It appears that the MEK freed Sp1 from its bound
state with the corepressors SMRT or NCoR and thereby helped
Sp1 to recognize the Sp1 target GC-box and to activate
transcription.
The Sp1ZFDBD and the BCoR showed a particularly strong
molecular interaction. However, BCoR exhibited different re-
sults when exposed to ectopic MEKCA and MEKDN. Rather
than weakening the interactions occurring between
Sp1ZFDBD and BCoR, MEKCA increased the interaction (Fig.
6C), and MEKDN weakly increased the interaction between
Sp1ZFDBD and BCoR. The molecular interaction between
Sp1ZFDBD and BCoR can be regulated by MEK of the MAP
kinase/Erk kinase signaling pathway, but in the opposite way
compared with the SMRT/NcoR corepressor interaction.
Among the other components of the MAP kinase/Erk kinase
signaling pathway tested, the molecular interactions were not
significantly affected by the presence of ERK1, the ERK1 dom-
inant negative form MKP3, the RAF wild type, or the RAF
mutant form RAFS259A, and they appeared not to modulate
the interaction (data not shown).
These results suggest that the molecular context of the core-
pressors in a certain cell type might be critical in the regulation
of the transcription of many genes controlled by Sp1, because of
the modulation caused by the interactions between Sp1ZFDBD
and the corepressors.
The Molecular Interaction between the Sp1ID and the Core-
pressors Is Also Controlled by MEK in Vivo—The molecular
interactions occurring between the Sp1ID and the corepressors
were tested in order to determine whether they could also be
regulated by a component of the MAP kinase/Erk kinase sig-
naling pathway (Fig. 6, D–F). VP16-SMRT, -NCoR, and -BCoR
increased reporter activity strongly, suggesting a positive in-
teraction between the corepressors and Sp1ID. Most notably,
MEKCA drastically reduced molecular interactions, whereas
the addition of MEKDN increased interactions by 7-fold (Fig.
6D). Similar findings were also observed with the Sp1ZFDBD
and the corepressor NCoR (Fig. 6E). These results suggest that
the molecular interactions between Sp1ID and the corepressors
SMRT or NCoR can be weakened by MEK, and that Sp1ID
could be freed from the corepressor-bound state by MEK, just
as for Sp1ZFDBD. MEK may allow the Sp1 bound on the
regulatory sequence to activate transcription by freeing the
corepressors. As observed in the Sp1ZFDBD, MEK showed
different effects on the molecular interactions between Sp1ID
and BCoR. MEKCA strongly increased the interaction between
Sp1ID and BCoR, but MEKDN showed very weak or no signif-
icant effects (Fig. 6F).
Our data suggest that the interactions between Sp1ID and
the corepressors can be modulated by MEK, and that the mo-
lecular context of the corepressors in a certain cell type is
important for transcriptional regulation in many genes con-
trolled by Sp1, as the interactions are differentially regulated
depending on the corepressors involved.
MAP Kinase Activator EGF and U0126 MEK Inhibitor of the
MAP Kinase/Erk Kinase Signaling Pathway Control the Tran-
scription of the pG5–5x(GC)-Luc Promoter—We tested whether
the MAP kinase/Erk kinase signaling pathway was able to
regulate the molecular interactions involving Sp1ZFDBD, us-
ing the Sp1-regulated test promoter reporter fusion construct,
pG5–5x (GC)-Luc, in the presence of the MAP kinase activator
EGF and the U0126 MEK inhibitor. The reporter pG5–5x(GC)-
Luc responds well to both EGF and U0126. EGF-activated
transcription and the MEK inhibitor also repressed transcrip-
tion, which suggests that the MAP kinase/Erk kinase signaling
pathway does control Sp1 activity in this test promoter (Fig.
7A). We also tested whether EGF and U0126 could regulate the
transcription of the two well characterized Sp1-dependent hu-
man gene promoters, p21Waf/Cip1 and ADH5/FDH. The treat-
ment of transfected cells with EGF and U0126 resulted in
FIG. 5. ChIP assay of pG5-Luc in CV-1 cells: Gal4-Sp1ID and
Sp1ZF bind to the UAS promoter element of pG5-Luc, and
deacetylate histone in vivo. A, molecular interaction between
Gal4Sp1ID or Gal4 and UAS promoter regulatory elements of pG5-Luc.
The arrows indicate the locations of PCR primers relative to the tran-
scription start site. Tsp, transcription start site. B, ChIP assay of the
pG5-Luc promoter using antibodies against acetylated histone 3 and
histone 3K9. Rabbit IgG was used as a control ChIP antibody. CV-1
cells were transfected with pG5-Luc and pCMX-Gal4, pCMXGal4-
Sp1ID, or -Sp1ZF expression plasmid and immunoprecipitated with
antibodies indicated. C, hypothetical mechanism for histone deacetyla-
tion and transcription repression by Sp1ID and interacting corepres-
sors. Corepressors and HDAC complex interacting with Sp1 inhibitory
domain may deacetylate histone, make nucleosome compact, and re-
press transcription in certain promoter context.
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FIG. 6. The interactions between
the Sp1ZFDBD or Sp1ID and the
corepressors can be modulated by
the MEK of MAP kinase/Erk kinase
signaling pathway. A–C, mammalian
two-hybrid assays demonstrate that the
molecular interactions between the
Sp1ZFDBD and the corepressors (SMRT,
NCoR, and BCoR) can be modulated by
MEK, a component of the MAP kinase
pathway. The presence of MEKCA atten-
uates the interaction and MEKDN aug-
ments the interaction, suggesting that
MEK disrupts the interaction between
Sp1ZFDBD and the corepressors SMRT
and NCoR, renders more Sp1ZFDBD
available for promoter binding, and acti-
vates transcription. However, upon
MEKCA expression, BCoR exhibited an
opposite effect compared with SMRT/
NCoR. D–F, molecular interactions be-
tween the Sp1ID and corepressors
(SMRT, NCoR) can be also modulated by
MEK. The presence of the constitutive ac-
tivator form of MEK attenuates the inter-
action, and the MEKDN form increases
interaction, suggesting that MEK dis-
rupts the interaction. However, BCoR
showed an opposite effect compared with
SMRT/NCoR, and MEKCA increased in-
teractions between the Sp1ID and the
corepressors. The cell extracts were ana-
lyzed for their reporter luciferase activi-
ties and were normalized with -galacto-
sidase activity. Data are an average of
three independent assays. Bar represents
S.D.
FIG. 7. Transcription on the pG5–5x(GC)-Luc, p21Waf/Cip1-Luc, and ADH5/FDH-Luc can be increased by MAP kinase activator EGF
and repressed by U0126 MEK inhibitor. CV-1 cells were transfected with the various promoter-luciferase fusion plasmids (0.8 g) and
pCMV--gal (0.2 g), and the cells were treated with EGF (50 ng/ml) or U0126 (10 nM) for 24 h prior to harvest. The cell extracts were analyzed
for their reporter luciferase activities and normalized with -galactosidase activity or protein concentration. Data are an average of four
independent assays. Bar represents S.D.
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modulations of transcription similar to what was observed with
pG5–5x(GC)-Luc (Fig. 7, B and C).
The MEK Constitutively Active MEKCA and Dominant Neg-
ative Form MEKDN of the MAP Kinase/Erk Kinase Signaling
Pathway Control the Transcription of Sp1-dependent pG5–
5x(GC)-Luc and p21Waf/Cip1-Luc—We also tested whether the
transcription of the two Sp1-dependent promoters could be
modulated by MEK. The mammalian two-hybrid assay data
suggested that activated MEK could release the Sp1ZFDBD or
Sp1ID from the corepressor (SMRT/NCoR) complex and acti-
vate transcription. We tested this possibility by co-transfecting
CV-1 cells with pG5–5x(GC)-Luc or p21Waf/Cip1-Luc, with the
plasmid expressing MEKCA or MEKDN. MEKCA was able to
activate transcription, and MEKDN repressed MEKCA-in-
duced transcription activation (Fig. 8). Overall, these data
(Figs. 2–7) suggest that molecular interactions exist between
Sp1ZFDBD or Sp1ID and the corepressors (SMRT, NcoR, and
BcoR), and that the interactions are regulated by MEK.
Knockdown of the Corepressors by siRNA Treatment In-
creases the Transcription of the Sp1-dependent Promoter—The
interactions between the Sp1ZFDBD or Sp1ID and the core-
pressors might repress transcription by inhibiting the GC-box
target recognition of Sp1. Another possibility is that the core-
pressor proteins repress transcription by being recruited via
the Sp1ID domain onto the promoter-bound Sp1. To character-
ize the functional significance of this molecular interaction on
Sp1-controlled transcription, we knocked down the expression
of the endogenous corepressors by treating human HeLa cells
with an siRNA pool designed to destroy the mRNA of SMRT,
NCoR, and BCoR. The Sp1-dependent reporter plasmid, pG5–
5x(GC)-Luc, was cotransfected with the siRNA pool (SMRT,
NCoR, and BCoR) into HeLa cells, and the luciferase reporter
gene expression was analyzed. Treatment with the siRNA pool
significantly reduced the mRNA levels of NCoR, SMRT, and
the glyceraldehyde-3-phosphate dehydrogenase control, while
-actin mRNA remained unchanged (Fig. 9A). The BCoR
mRNA was detected in neither the control nor the siRNA-
treated HeLa cells, suggesting that BCoR mRNA was not ex-
pressed in the HeLa cells (Fig. 9A). The disruption of corepres-
sor expression resulted in a 1.7-fold increase in the
transcription of the Sp1-dependent test promoter (Fig. 9B).
This suggests that knocking down the mRNA of the corepres-
sors via siRNA treatment might result in the liberation of
Sp1ZFDBD from the corepressors, thus enhancing Sp1 target
recognition and activating transcription. Also, it is possible
that the siRNA treatment resulted in a depletion of the
corepressors that could be recruited to the Sp1ID of the
proximal promoter-bound Sp1, and thereby activating
transcription.
FIG. 9. Knockdown of the corepressors by siRNA-increased
transcription of pG5–5x(GC)-Luc. The HeLa cells were cotrans-
fected with the siRNA pool of corepressors (20 ng each of SMRT, NCoR,
and BCoR), along with pG5–5x(GC)-Luc (0.3 g) and pCMV--gal (0.1
g). The cell extracts were analyzed for their reporter luciferase activ-
ities and normalized with -galactosidase activity and protein concen-
tration. A, siRNA treatment resulted in a significant destruction of the
corepressor mRNA and GAPDH control mRNA. -actin mRNA remains
unchanged. The mRNA of BCoR was detected in neither treated nor
untreated HeLa cells. B, knocking out the corepressors resulted in the
activation of Sp1-dependent transcription of pG5–5x(GC)-Luc. Data are
an average of three independent assays. Bar represents S.D.
FIG. 8. Transcription on the pG5–
5x(GC)-Luc (A) and p21Waf/Cip1-Luc
(B) can be activated by MEKCA, and
the activation is decreased by
MEKDN. The CV-1 cells were transfected
with various promoter-luciferase fusion
plasmids (0.2 g), MEKCA, or MEKDN
expression plasmids (0.8 g), and pCMV--
gal (0.2 g). The cell extracts were analyzed
for their reporter luciferase activities and
were normalized to -galactosidase activity
or protein concentration. Data are expressed
as an average of four independent assays.
Bar represents S.D.
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DISCUSSION
The molecular mechanisms underlying biological processes
can be understood by investigating the network of protein-
protein interactions involved. The Sp1 transcription factor reg-
ulates gene expression by binding to the GC boxes located in
the proximal promoters of many cellular and viral genes (3–5).
Sp1 was initially purified and isolated as a transcription factor
that could recognize the SV40 early promoter (1, 2), also form-
ing a family with factors such as Sp2–8 (3–5). Thus far, Sp1 has
been demonstrated to interact with various proteins (e.g. TBP,
dTAF110, TAFII130, TAFII55, Rb, YY1, E2F, CRSP, FBI-1,
p300, HAT, etc.), and these interactions have proved to be
crucial in the regulation of many cellular functions by tran-
scription-level control of gene expression. We, along with other
investigators (9, 21, 22), determined that the most highly con-
served region of Sp1, the Sp1ZFDBD, is involved in protein-
protein interactions with other proteins, including the POZ
domains of FBI-1, p300, and HDAC1.
We showed in this report that the Sp1ZFDBD interacts with
corepressors (SMRT, NCoR, and BCoR), and that the interac-
tions are important in the regulation of Sp1 activity and the
transcription of Sp1-dependent promoters. Our data suggest
that the Sp1ZFDBD might not be in a naked state and that
instead, Sp1ZF is associated with the corepressors. The molec-
ular interactions provide an intriguing and novel mechanism
for regulating Sp1 activity at the level of GC-box target recog-
nition by the Sp1ZF (Fig. 10).
In addition, the molecular interactions between Sp1ID and
the corepressors can explain how Sp1 can function as a tran-
scription repressor in certain Sp1-bound promoters (23–27),
even though Sp1 is known to be a transcription activator, in
general (Refs. 3–5 and references therein) (Fig. 10).
Considering the fact that the ZFDBD is the most highly
conserved domain in the Sp-family transcription factors, with
84–95% amino acid sequence homology among Sp1–6 (3), the
interactions might also exist in the ZFDBDs of the other mem-
bers of the Sp-family, and the interactions may be important in
the regulation of transcription by the Sp-family. Preliminary
studies with the other Sp-family members indicate that the
interactions are indeed present with Sp3 and Sp4.2 Because
few studies have been done with Sp2, Sp5, or Sp6 in the
transcriptional regulation of GC-box-containing promoters, we
have scant evidence of how they might contribute to transcrip-
tion regulation. However, it appears that Sp1 has the most
potent transcription activation potential, while Sp4 activates
transcription rather weakly and Sp3 mostly represses tran-
scription (14). Accordingly, the transcription of a particular
2 J.-A. Lee, M.-H. Kim, and M.-W. Hur, manuscript in preparation.
FIG. 10. Model for transcriptional
regulation of Sp1 transcription fac-
tor by interactions between the
Sp1ZFDBD or Sp1ID with the core-
pressors SMRT, NCoR, and BCoR. A
and B, Sp1ZFDBD is bound by the core-
pressors SMRT and NCoR, and has no
access to the target Sp1-binding GC boxes
in the promoters or the enhancers. How-
ever, if MEK acts on Sp1ZFDBD or on the
corepressors, Sp1ZFDBD is freed, and can
bind to the GC boxes and activate tran-
scription. In contrast, the interaction be-
tween Sp1ZFDBD and BCoR is aug-
mented by MEK. C and D, interactions
between SP1ID and the corepressors,
SMRT and NCoR, are identical to that
observed with Sp1ZFDBD. The interac-
tion between Sp1ZFDBD and BCoR is
augmented by MEK.
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GC-box-containing promoter is more likely to be controlled by
Sp1. Indeed, the molecular interactions between Sp4 and the
corepressors are at least 3–5 times stronger, as revealed by
mammalian two-hybrid assays (data not shown). This suggests
that Sp4 is most likely still associated with corepressors in the
situation where most Sp1 molecules have been freed to bind the
target GC-box and activate transcription.
Previously, it has been reported that members of the Sp-
family could clearly be regulated by phosphorylation, glycosy-
lation, acetylation, and SUMOylation (6–10). In addition, the
Sp1 binding GC-box sites in the p21Waf/Cip1 promoter and
urokinase are the targets of the MAP kinase/Erk kinase sig-
naling pathway, suggesting that Sp1 recognition of the GC-box
sites might be the target of MAP kinase/Erk kinase signaling
(36, 37). Because controlling DNA binding and protein interac-
tions with the corepressors via ZFDBD or ID could be impor-
tant functions in regulating Sp1 activity, it was assumed that
the molecular interactions between Sp1 and the corepressors
might be the target of the MAP kinase signaling pathway,
which could thereby regulate the transcription of the Sp1-de-
pendent promoters. We tested whether the MAP kinase signal-
ing pathway could regulate molecular interaction between
Sp1ZFDBD and the corepressors, using the Sp1-dependent
pG5–5x(GC)-Luc fusion reporter plasmid and mammalian two-
hybrid assay. Treatment of the transfected cells with EGF and
U0126 MEK inhibitor, or the ectopic expressions of MEKCA
and MEKDN, modulated the molecular interactions between
Sp1ZFDBD or Sp1ID and the corepressors. The Sp1 reporter
pG5–5x(GC)-Luc itself and native human gene promoters re-
sponded well to EGF and U0126, and MEKCA activated tran-
scription. Overall, these results suggest that molecular inter-
actions do occur between Sp1ZFD or Sp1ID and the
corepressors, and that these interactions are modulated by
MEK. These results are in line with previous reports that the
Sp1-dependent promoter was controlled by the MAP kinase
signaling pathway, as has been reported for the p21Waf/Cip1
promoter (36–38, 40, 41).
It has been suggested that MEK, from the MAP kinase
pathway, phosphorylates Sp1 at amino acids 453 and 739 (36,
38, 40). The phosphorylation of these two sites results in an
increase in Sp1 binding to the target sites and in increased
transcription activation. However, the Sp1ZFDBD (amino ac-
ids 622–720) and Sp1ID (amino acids 1–82) used in this assay
do not contain the two phosphorylation sites. Therefore, MEK
more likely functions by phosphorylating the corepressor mol-
ecules, thus controlling the molecular interactions between
Sp1ZFDBD or Sp1ID and the corepressors. Previously, the
ability of SMRT to associate with a variety of transcription
factors such as nuclear hormone receptors, PLZF, and Bcl-6,
and thereby to mediate repression, was shown to be strongly
repressed by the phosphorylation of SMRT by MEKK1 or
MEK-1 of the MAP kinase pathway (42, 43). More recently, it
was demonstrated that the protein-protein interactions be-
tween the C-terminal nuclear receptor interaction domains of
SMRT (S1, S2 domains; amino acids 1733–2471) or NCoR
(N1–3 domains; amino acids 1946–2435) and TR or RAR are
differentially regulated by MEKK1, depending on the repres-
sors (43). The domain of the corepressors used in our assays is
the domain that has been implicated in the repression of tran-
scription via interaction with the POZ domains, PLZF or Bcl-6.
This is a different domain from those (C-terminal) investigated
by Privalsky and co-workers (42, 43).
The molecular interactions occurring between Sp1 and the
corepressors do not appear to be unique to Sp1 and can be
found in the other members of the Sp-family or the Sp-like
transcription factors. Although different corepressors are in-
volved, Sp1-like transcription repressors like the BTEB-family
and TIEG1–2 have been demonstrated to interact with another
corepressor molecule, the mammalian Sin3A (mSin3A), via the
Sin3-interacting domain (SID) (39, 44, 45). This interaction is
important in the repression of transcription. Intriguingly, the
interaction is inhibited by the EGF-Ras-MEK1-ERK2 signaling
pathway, which disrupts SID-mSin3A interactions, thereby in-
hibiting repression activity (39).
Our data suggest that the molecular interactions occurring
between the Sp1ZFDBD or Sp1ID and the corepressors NcoR
and SMRT may constitute an important regulatory aspect of
numerous cellular and viral gene expressions controlled by Sp1
and the related Sp-family (Fig. 10). Our data also suggest that
a MAP kinase/Erk kinase signaling process can regulate mo-
lecular interactions, and that the type of regulation can differ
according to the types of corepressors involved in the interac-
tions. Accordingly, the cellular contexts of SMRT, NCoR, and
BCoR may also be important in the MEK-mediated transcrip-
tional regulation of Sp1, as MEK weakens the interaction be-
tween Sp1ZFDBD or Sp1ID and SMRT or NCoR. In contrast,
MEK intensifies the interactivity between Sp1ZFDBD or
Sp1ID and BCoR.
In summary, the activity of the Sp1 transcription factor can
be regulated by a novel protein-protein interaction that in-
volves Sp1ZFDBD or Sp1ID and the corepressors. The mecha-
nism by which the interaction is modulated by the MAP kinase
signaling pathway, and the cellular context of the corepressors,
may be crucial to the regulation of the expression of many
other cellular and viral genes controlled by Sp1, the Sp-
family, and perhaps other more extended Kru¨ppel-like zinc
finger transcription factors harboring highly conserved C2H2-
type zinc fingers.
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